Hemrajani Rekha

Hemrajani Rekha is listed in filings as Director at ALX Oncology Holdings Inc.. This profile follows SEC Form 4 activity through Jan 21, 2026, including sale activity and purchase activity. Recent filings connect the profile to ALX Oncology Holdings Inc. (ALXO), MaxCyte, Inc. (MXCT), and BioAge Labs, Inc. (BIOA). The current snapshot covers public activity from Jun 13, 2024 to Jan 21, 2026. Reported amounts are shown as $53.3K to $107.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.